Day: May 28, 2024

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024 Lausanne, Switzerland, May 28, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering the development of precision medicine approaches for the diagnosis, treatment, and prevention of neurodegenerative diseases, today announced that Company Management will participate in a fireside chat and one-on-one investor meetings during the Jefferies 2024 Global Healthcare Conference, taking place in-person in New York on June 5-6, 2024. The fireside chat will take place on Wednesday, June 5 at 3:30 PM (ET). A webcast of the fireside chat will be available at https://wsw.com/webcast/jeff302/aciu/1825568 as well as on the Events Page of AC Immune’s website. A replay will be archived in the same location. Please contact your Jefferies representative...

Study successfully demonstrated Predictive’s ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients better than clinical data alone PITTSBURGH, May 28, 2024 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that positive results from a retrospective study that the company recently completed in collaboration with UPMC Magee-Womens Hospital will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which is being held May 31-June 4, 2024, in Chicago, Il. The purpose of the study was to determine if Predictive Oncology could leverage its artificial intelligence and other capabilities to develop machine learning (ML) models that could more accurately predict both short-term...

Expanded C-level team poised to accelerate development of NX-5948 in B cell malignancies SAN FRANCISCO, May 28, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today announced the appointments of Paula G. O’Connor, M.D., as chief medical officer and Pasit Phiasivongsa, Ph.D., as chief technical officer of Nurix. “I am delighted to announce the promotions of both Paula and Pasit, which recognize their significant and ongoing leadership in advancing our pipeline of novel medicines and particularly in accelerating our NX-5948 program in chronic lymphocytic leukemia and non-Hodgkin’s lymphoma,” said Arthur T. Sands, M.D., Ph.D., president and chief executive officer...

NORWALK, Conn., May 28, 2024 (GLOBE NEWSWIRE) — FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, announced today that it will release its financial and operating results for the third quarter fiscal 2024, ending May 31, 2024 on Friday, June 21, 2024. FactSet will also host a conference call to discuss these results at 11:00 a.m. Eastern Time on Friday, June 21, 2024. The following information is provided for investors who would like to participate in the conference call: Third Quarter Fiscal 2024 Conference Call DetailsDate: Friday, June 21, 2024Time: 11:00 a.m. Eastern TimeParticipant Registration: FactSet Q3 2024 Earnings Call Registration   Please register for the conference call using the above link before the call start time. The conference call platform...

VAL-D’OR, Quebec, May 28, 2024 (GLOBE NEWSWIRE) — Cartier Resources Inc. (TSXV: ECR, FSE: 6CA) (the “Company”) announces the termination, effective May 23, 2024, of the option agreement (Original Agreement, April 22nd 2021 and Amended Agreement, April 20th 2023) pertaining to its 100% owned Wilson Property, situated 15 km east of Lebel-sur-Quévillon, due to the third anniversary earn-in commitments not being met by the optionor, which was notified accordingly. The project has three key exploration success components:LocationMining camp jurisdiction of Quebec, Canada Infrastructures and qualified workersHigh grade gold mineralizationTrench and drill hole with multiple high grade gold intersections High grade gold Toussaint Deposit open below 200 mBlue-skyNumerous high grade gold discoveries with expansion potential Compilation...

Production scale order from a U.S. based Tier-1 defense & drone manufacturer for Mobilicom’s solution integration into drone platforms deployed with a growing slate of end-users Shoham, Israel, May 28, 2024 (GLOBE NEWSWIRE) — Mobilicom Limited (Nasdaq: MOB, MOBBW), a provider of cybersecurity and robust solutions for drones and robotics, today announced it has received a third consecutive commercial scale order from a U.S.-based Tier-1 customer, one of the largest drone manufacturers in the world.The customer purchased Mobilicom’s SkyHopper PRO, a bi-directional cybersecure Software Defined Radio (SDR) datalink system, which has been designed into the customer’s drone platform that is being manufactured for the U.S. Department of Defense (DoD), the broader U.S. defense industry, and other U.S. federal agencies. “We are pleased...

MELBOURNE, Australia, May 28, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX007-CDx, a new and proprietary cold kit (“Kit”) for the preparation of PSMA-PET imaging1 for prostate cancer. Subject to regulatory approval, this Kit will enable use of a PSMA imaging product with a considerably extended distribution profile compared to currently approved gallium-68 (68Ga) PSMA-PET imaging agents. The Kit’s innovative properties are designed to facilitate more flexible production, including with 68Ga sourced from both newer high activity generators and cyclotrons powered by the ARTMS® QUANTM Irradiation System™2 and GE FASTlab™3 solid and liquid target production...

Tuesday, June 18, 2024 at 8:00 am Eastern Time PONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside chat at the Truist Securities MedTech Conference on Tuesday, June 18, 2024, beginning at approximately 8:00 am Eastern Time. A live webcast and replay of the fireside chat will be available on the Company’s investor relations website at https://investors.treace.com/. Internet Posting of Information Treace routinely posts information that...

LOUISVILLE, Ky., May 28, 2024 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage and media solutions, today announced that it and First Merchants Bank (“FMB”) executed a credit agreement implementing the previously-announced $22.1 million senior secured revolving credit facility (the “Revolver”) with a $5 million accordion feature. At closing, the Revolver was utilized to pay off all existing indebtedness of the Company – $13.6 million – along with closing costs and ancillary fees. Additional terms were disclosed in the Company’s Current Report on Form 8-K filed with the SEC on the date of this release. “We are pleased to announce that a new credit facility with First Merchants, as anticipated, has been consummated, paving the way for...